Clinical trial

Patients With Brain Metastases From HER2-positive Breast Cancer

NCT02135159

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-01

PhasePHASE1

Study timeline

Study start (unknown)2014-02-01Date precision: month

Registry last updated2017-08-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HER2-positive Breast Cancerunresolved

Interventions

TDM1DRUG

Brain Sequential RTRADIATION

Sponsors & collaborators

Institut du Cancer de Montpellier - Val d'Aurellelead sponsor

Mapped research locations

MontpellierFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02135159 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.